Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125090262 | 12509026 | 2 | F | 20160711 | 20160629 | 20160718 | EXP | CN-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-41018CS | BOEHRINGER INGELHEIM | MIN H. NURSING OF ADD IN IPRATROPIUM BROMIDE CHILD WHEN THROUGH VENOUS TRANSFUSION ONE CASE. WORLD LATEST MEDICINE INFORMATION 2016;15(30):P233. | 1.00 | MON | M | Y | 0.00000 | 20160718 | OT | COUNTRY NOT SPECIFIED | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125090262 | 12509026 | 1 | PS | ATROVENT | IPRATROPIUM BROMIDE | 1 | Intravenous (not otherwise specified) | U | 21527 | 1.25 | ML | ||||||||
| 125090262 | 12509026 | 2 | SS | ATROVENT | IPRATROPIUM BROMIDE | 1 | U | 21527 | |||||||||||
| 125090262 | 12509026 | 3 | SS | PENICILLIN | PENICILLIN | 1 | Intravenous (not otherwise specified) | U | 0 | ||||||||||
| 125090262 | 12509026 | 4 | SS | PENICILLIN | PENICILLIN | 1 | U | 0 | |||||||||||
| 125090262 | 12509026 | 5 | C | CEFOTAXIME SODIUM | CEFOTAXIME SODIUM | 1 | Intravenous (not otherwise specified) | FORMULATION: INJECTION | 0 | ||||||||||
| 125090262 | 12509026 | 6 | C | CEFOTAXIME SODIUM | CEFOTAXIME SODIUM | 1 | 0 | ||||||||||||
| 125090262 | 12509026 | 7 | C | DOBUTAMINE | DOBUTAMINEDOBUTAMINE HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 125090262 | 12509026 | 8 | C | DOBUTAMINE | DOBUTAMINEDOBUTAMINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125090262 | 12509026 | 9 | C | DOPAMINE | DOPAMINEDOPAMINE HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 125090262 | 12509026 | 10 | C | DOPAMINE | DOPAMINEDOPAMINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125090262 | 12509026 | 1 | Cough |
| 125090262 | 12509026 | 2 | Wheezing |
| 125090262 | 12509026 | 3 | Cough |
| 125090262 | 12509026 | 4 | Wheezing |
| 125090262 | 12509026 | 5 | Cough |
| 125090262 | 12509026 | 6 | Wheezing |
| 125090262 | 12509026 | 7 | Cough |
| 125090262 | 12509026 | 8 | Wheezing |
| 125090262 | 12509026 | 9 | Cough |
| 125090262 | 12509026 | 10 | Wheezing |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125090262 | 12509026 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125090262 | 12509026 | Cardiac failure | |
| 125090262 | 12509026 | Cardiomyopathy | |
| 125090262 | 12509026 | Hepatic function abnormal | |
| 125090262 | 12509026 | Pneumonia | |
| 125090262 | 12509026 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125090262 | 12509026 | 1 | 20150815 | 0 | ||
| 125090262 | 12509026 | 3 | 20150815 | 0 |